CalcMyPeptide
Khavinson BioregulatorAlso known as: Pancreas Extract Bioregulator, Pancreatic Cytomax

Suprefort

Suprefort is an elite Cytomax natural bioregulator composed of comprehensive peptide fractions extracted directly from the pancreas of young animals. Unlike Pancragen (which solely targets beta-cells), Suprefort orchestrates total, full-spectrum pancreatic regeneration. It is universally utilized to reverse severe exocrine insufficiency, massively upregulate endogenous digestive enzyme production, and profoundly stabilize insulin output in aging metabolisms.

Reviewed by CalcMyPeptide Editorial Team
Last updated: April 2026Evidence: Low1 peer-reviewed citation

Quick Stats

Half-LifeMixture (variable)
Dose Range1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Vial SizesN/A (oral)
BioavailabilityOral capsules
Year Developed1980s

Scientific Data

Molecular Formula
Polypeptide extract (Pancreatic tissue <10 kDa)
Molecular Weight
Mixture (<10 kDa)
PubChem ID

Mechanism of Action

Suprefort (A-1) is a Cytomax natural polypeptide extract from the pancreas of young calves — the first numbered entry in the entire Khavinson A-Series, reflecting its foundational metabolic importance. The pancreas performs two critical functions: exocrine (secreting digestive enzymes into the small intestine) and endocrine (secreting insulin, glucagon, and somatostatin via the islets of Langerhans). Age-related pancreatic decline manifests on both fronts: progressive loss of exocrine acinar cell function reduces digestive enzyme output (contributing to malabsorption and bloating after age 50), while beta-cell insufficiency reduces insulin secretion capacity and/or insulin sensitivity — the upstream driver of type 2 diabetes.

Suprefort delivers short peptide signals (<10 kDa) from bovine pancreatic tissue. These peptides enter pancreatic cell nuclei to reactivate age-silenced transcription factors governing: insulin gene expression (PDX-1, NeuroD1 — the master regulators of beta-cell identity), digestive enzyme synthesis (amylase, lipase, trypsinogen), and islet cell proliferation capacity. Critically, Suprefort does not provide exogenous insulin or lower blood glucose directly — it works at the gene regulation level to restore the pancreas's own capacity to mount an appropriate insulin and enzyme response.

In Khavinson's clinical data, courses of pancreatic bioregulators were associated with improved post-prandial glucose control and reduced fasting glucose variability. The standard pairing is Suprefort (A-1, pancreas) + Svetinorm (A-7, liver) for comprehensive metabolic axis support, since hepatic insulin sensitivity and glucose output are tightly coupled to pancreatic insulin secretion.

Source: PMID: 15677927

Background & History

Suprefort is the pancreatic Cytomax extract — natural counterpart to synthetic Pancragen.

Research Use Cases

  • Pancreatic function
  • Digestive enzyme support
  • Metabolic regulation

Dosing Protocol

Typical Dose1-2 capsules/day
Frequency1-2× daily for 10-30 day cycles
Half-Life~30 minutes (estimated)

Dosing Protocols

Mini-Course / General Preventive (1 box)

Dose
2 capsules (20 mg)
Frequency
Once daily for 10 days, 30 min before meals
Note: Standard Khavinson mini-course (20 caps). Repeat every 6 months. Most effective when taken before the largest meal of the day. Pair with Svetinorm (A-7) for the complete metabolic axis protocol.

Full Monthly Course (Metabolic Health)

Dose
2 capsules (20 mg)
Frequency
Twice daily for 30 days (120 caps = 2× 60-cap boxes)
Note: Bi-annual 30-day courses for pre-diabetic adults, metabolic syndrome, or declining digestive enzyme output. Core metabolic stack: Suprefort (A-1) + Svetinorm (A-7, liver) + Ventfort (A-3, blood vessels) for full metabolic-vascular health.

Intensive / Pancreatic Support Protocol

Dose
2 capsules (20 mg)
Frequency
Twice daily, repeated monthly
Note: For established metabolic dysfunction, significant digestive enzyme insufficiency, or post-pancreatitis recovery. Physician supervision mandatory for any diabetic patient. Not a replacement for insulin therapy. Max: 4 caps/day (40 mg).

Administration

Route
Oral capsules (20-cap and 60-cap boxes)
Timing
30 minutes before the largest meal of the day. This timing maximizes peptide contact with gut mucosa before peak digestive demand.
Fasting Required?
Yes — inject on an empty stomach

Expected Timeline

Days 1—14
Pancreatic cell gene expression restoration initiated. Reduced post-meal bloating reported early by users with exocrine insufficiency.
Month 1–3
Improved glucose curve stability after meals. Better digestive enzyme transit through reduced GI discomfort.
Month 3–6
Sustained islet cell function improvement. Long-term: glucose regulation stability in metabolically compromised individuals.

Who Is It For?

Metabolic Syndrome / Pre-Diabetes (Ages 45+)

Low

Restores pancreatic beta-cell gene expression for insulin synthesis and secretory capacity. For preventive metabolic management, not acute glycemic control.

Digestive Enzyme Insufficiency

Low

Also targets exocrine acinar cells restoring amylase, lipase, and protease production — addressing the often-overlooked digestive aspect of pancreatic aging.

Safety & Considerations

Natural glandular extract (Cytomax) from bovine pancreatic tissue, <10 kDa. Contains no insulin or active hormones. Not a diabetes medication. Meets European/Russian veterinary standards. Physician oversight required for diabetic patients.

Regulatory & Legal Status

FDA Status (US)
Research Only
WADA Status (2026)
Not Listed

Not currently on the WADA 2026 Prohibited List. Policies may change — verify before competition.

Classification

Research Chemical

US Compounding: Not eligible / not available

⚠️ This information is for educational purposes only and may not reflect the most current regulatory updates. Always verify with official FDA, WADA, and jurisdiction-specific sources before use.

Interactions & Contraindications

Monitor blood glucose in diabetic patients.

Synergies & Common Stacks

Suprefort (Cytomax) + Pancragen (synthetic) = layered pancreatic support.

Dosing Quick Reference

Suprefort— Dosing Guide
Dose Range
1-2 capsules/day
Half-Life
~30 minutes (estimated)
Frequency
1-2× daily for 10-30 day cycles
Route
Oral
Khavinson Bioregulatorcalcmypeptide.com

Frequently Asked Questions

Can Suprefort help with blood sugar?
Suprefort works at the gene expression level — it reactivates the transcription factors (PDX-1, NeuroD1) that define beta-cell identity and insulin secretory capacity. It is not a blood sugar medication and should not be used in place of prescribed diabetic therapy, but may be used as a complementary restorative protocol under physician oversight.
Why is Suprefort A-1 — the very first in the series?
Khavinson numbered the A-Series roughly by systemic importance. The pancreas governs both digestion (exocrine) and metabolic regulation (endocrine/insulin) — making it foundational to energy metabolism, digestive health, and longevity. A compromised pancreas affects every other organ system.

References

  1. Khavinson VKh "Peptide bioregulators — a new class of geroprotectors".” Bulletin of Experimental Biology and Medicine (2002). PMID: 12677266

📚 Related Articles

Recommended SourceOral Bioregulator

Get Suprefort from Vita-Stream — the comprehensive distributor for authentic Khavinson bioregulators. Oral capsules, no injections required.

Affiliate link · Full review